LCD L36021: MolDX: Molecular Diagnostic Tests (MDT) — CGS
Policy LCD-L36021 · Clinical Laboratory
New MolDX policy effective in 2025 may alter billing processes.
Code intelligence
0114U reimbursement alerts
Policy changes, MAC LCD updates, and CMS guidance matched to code 0114U.
Elevated code risk
Signal breakdown
6 shown · 6 total in platform
Risk: Elevated
0
Critical
0%
6
High
100%
0
Routine
0%
0
Low
0%
New this month
—
alerts added in last 30 days
Effective soon
—
no upcoming deadlines
High
LCD L39262: MolDX: Molecular Testing for Detection of Upper Gastrointestinal Metaplasia, Dysplasia, and Neoplasia — Noridian
Policy LCD-L39262 · Gastroenterology
New LCD impacts gastro testing billing from 2026.
LCD L39276: MolDX: Molecular Testing for Detection of Upper Gastrointestinal Metaplasia, Dysplasia, and Neoplasia — CGS
Policy LCD-L39276 · Gastroenterology
New molecular testing guidelines affect billing practices.
LCD L39264: MolDX: Molecular Testing for Detection of Upper Gastrointestinal Metaplasia, Dysplasia, and Neoplasia — Noridian
Policy LCD-L39264 · Gastroenterology
New coverage for upper GI molecular testing effective 2025.
LCD L36256: MolDX: Molecular Diagnostic Tests (MDT) — Noridian
Policy LCD-L36256 · Clinical Laboratory
New molecular diagnostics policy may impact billing processes.
LCD L35160: MolDX: Molecular Diagnostic Tests (MDT) — Noridian
Policy LCD-L35160 · Clinical Laboratory
New MolDX guidelines may alter MDT billing processes.
Audit documentation
Building an audit file that includes 0114U?
The Tripwire Audit Pack exports 12 months of Clinical Laboratory policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.
Get the Clinical Laboratory audit pack — $349One-time purchase · not a subscription